Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rupatadine in Chronic Spontaneous Urticaria (CU-LATER)
NCT02358265Phase 3Terminated
- Sponsor
- Charité – Universitätsmedizin Berlin
- Start
- Dec 2014
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of rupatadine in chronic spontaneous urticaria (CSU), sponsored by Charité – Universitätsmedizin Berlin. Started Dec 2014; status: terminated.
02
Drugs
rupatadine
03
Conditions
chronic spontaneous urticaria (CSU)
Beyond the preview
Go deeper on NCT02358265.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02358265.